We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Tenet Healthcare (THC) Outpaces Stock Market Gains: What You Should Know
Read MoreHide Full Article
Tenet Healthcare (THC - Free Report) ended the recent trading session at $196.33, demonstrating a +1.01% change from the preceding day's closing price. The stock exceeded the S&P 500, which registered a gain of 0.88% for the day. On the other hand, the Dow registered a gain of 0.38%, and the technology-centric Nasdaq increased by 1.31%.
The hospital operator's shares have seen an increase of 4.12% over the last month, surpassing the Medical sector's gain of 1.2% and the S&P 500's gain of 2.48%.
The investment community will be closely monitoring the performance of Tenet Healthcare in its forthcoming earnings report. The company's upcoming EPS is projected at $4.05, signifying a 17.73% increase compared to the same quarter of the previous year. Simultaneously, our latest consensus estimate expects the revenue to be $5.45 billion, showing a 7.44% escalation compared to the year-ago quarter.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $16.15 per share and revenue of $21.27 billion. These totals would mark changes of +35.94% and +2.91%, respectively, from last year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Tenet Healthcare. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Tenet Healthcare is currently sporting a Zacks Rank of #3 (Hold).
In terms of valuation, Tenet Healthcare is currently trading at a Forward P/E ratio of 12.04. For comparison, its industry has an average Forward P/E of 8.71, which means Tenet Healthcare is trading at a premium to the group.
We can also see that THC currently has a PEG ratio of 0.85. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. As of the close of trade yesterday, the Medical - Hospital industry held an average PEG ratio of 0.85.
The Medical - Hospital industry is part of the Medical sector. This group has a Zacks Industry Rank of 184, putting it in the bottom 26% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Tenet Healthcare (THC) Outpaces Stock Market Gains: What You Should Know
Tenet Healthcare (THC - Free Report) ended the recent trading session at $196.33, demonstrating a +1.01% change from the preceding day's closing price. The stock exceeded the S&P 500, which registered a gain of 0.88% for the day. On the other hand, the Dow registered a gain of 0.38%, and the technology-centric Nasdaq increased by 1.31%.
The hospital operator's shares have seen an increase of 4.12% over the last month, surpassing the Medical sector's gain of 1.2% and the S&P 500's gain of 2.48%.
The investment community will be closely monitoring the performance of Tenet Healthcare in its forthcoming earnings report. The company's upcoming EPS is projected at $4.05, signifying a 17.73% increase compared to the same quarter of the previous year. Simultaneously, our latest consensus estimate expects the revenue to be $5.45 billion, showing a 7.44% escalation compared to the year-ago quarter.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $16.15 per share and revenue of $21.27 billion. These totals would mark changes of +35.94% and +2.91%, respectively, from last year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Tenet Healthcare. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Tenet Healthcare is currently sporting a Zacks Rank of #3 (Hold).
In terms of valuation, Tenet Healthcare is currently trading at a Forward P/E ratio of 12.04. For comparison, its industry has an average Forward P/E of 8.71, which means Tenet Healthcare is trading at a premium to the group.
We can also see that THC currently has a PEG ratio of 0.85. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. As of the close of trade yesterday, the Medical - Hospital industry held an average PEG ratio of 0.85.
The Medical - Hospital industry is part of the Medical sector. This group has a Zacks Industry Rank of 184, putting it in the bottom 26% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.